Corporate News: Heartsciences Inc. (HSCS)
Market Performance (24 h to 11:44 PM Central Europe, Thursday 22 Feb 2026)
- Share price increased by 13.74 %.
- Current trading price: USD 3.17.
- Shares outstanding: 4.8 million.
- Market capitalization: USD 15 million.
- Volume traded in last 24 h: USD 840.2 k.
- 24‑h change since the end of the previous month: –22.78 %.
- 200‑day simple moving average: USD 2.71.
- 52‑week high: USD 5.25 (recorded 21 Sept 2026).
- 52‑week low: USD 1.63 (recorded 29 May 2026).
Recent Filing
Heartsciences Inc. has filed a definitive additional proxy statement (Schedule 14A) with the U.S. Securities and Exchange Commission (SEC). The filing relates to the company’s proposed all‑stock merger with Fortitude Mining Holdings, a digital‑asset mining company. The document contains:
- Explanatory notes and forward‑looking statements.
- Potential risks associated with the transaction’s completion.
- Risks related to integration of the two businesses.
- Risks tied to market conditions affecting digital assets.
Shareholders are urged to review the proxy materials, which will be mailed to shareholders. The documents are also available on the company’s investor‑relations website and on the SEC’s website. No filing fee was required for this submission.
24‑Hour Performance of Related Stocks
| Symbol | 24‑h Change | Current Price (USD) | Market Capitalization (USD mn) |
|---|---|---|---|
| RVP (Retractable) | 0 % | 0.58 | 17.4 |
| ACCS (Access Newswire) | –0.22 % | 4.57 | 17.5 |
| ATYR (Atyr Pharma) | –0.58 % | 0.17 | 17.6 |
| GIFT (Giftify) | +8.27 % | 0.55 | 18.0 |
| SCLX (Scilex) | +1.19 % | 2.47 | 17.8 |
Notes on Individual Companies
- Retractable: No change in price; market cap remains 17.4 mn.
- Access Newswire: Minor price decline; shares repurchased by InterContinental Hotels Group PLC on the London Stock Exchange at a price slightly above market level. No other material announcements.
- Atyr Pharma: Minor price decline; no significant events reported.
- Giftify: Price increased; company is preparing for its 2026 annual shareholders’ meeting (virtual, December). The meeting will cover director election and audit firm ratification.
- Scilex: Slight price increase; no additional information provided.
Company Overview
Heartsciences Inc. (Nasdaq: HSCS) is a medical‑device company headquartered in Colleyville, United States. The company focuses on coronary arterial disease diagnostics and treatment. Key facts:
- Sector: Health Care
- Business Focus: Medical devices for coronary arterial disease
- Website: www.hearttestlabs.com
- IPO Date: 14 June 2022
- Listing: Nasdaq Stock Market
For detailed financial statements, investor presentations, and regulatory filings, visit the company’s investor‑relations portal.